Atorvastatin Failed to Slow Atherosclerosis in Pediatric Lupus, Duke University Study

"Collectively, these results suggest that the potential benefits of statin therapy for slowing carotid intima medial progression are not large enough to warrant routine use in children with systemic lupus erythematosus," wrote Dr. Schanberg, professor of pediatrics and co-chief of the division of pediatric rheumatology at Duke University, Durham, N.C.

Back to news